BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33289846)

  • 1. Surgical Delay and Pathological Outcomes for Clinically Localized High-Risk Prostate Cancer.
    Xia L; Talwar R; Chelluri RR; Guzzo TJ; Lee DJ
    JAMA Netw Open; 2020 Dec; 3(12):e2028320. PubMed ID: 33289846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management after active surveillance for low-risk prostate cancer: pathological outcomes compared with men undergoing immediate treatment.
    Dall'Era MA; Cowan JE; Simko J; Shinohara K; Davies B; Konety BR; Meng MV; Perez N; Greene K; Carroll PR
    BJU Int; 2011 Apr; 107(8):1232-7. PubMed ID: 20804478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk Stratification of pN+ Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup.
    Moschini M; Sharma V; Zattoni F; Boorjian SA; Frank I; Gettman MT; Thompson RH; Tollefson MK; Kwon ED; Karnes RJ
    J Urol; 2016 Jun; 195(6):1773-8. PubMed ID: 26723866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does Time Spent on Active Surveillance Adversely Affect the Pathological and Oncologic Outcomes in Patients Undergoing Delayed Radical Prostatectomy?
    Ahmad AE; Richard PO; Leão R; Hajiha M; Martin LJ; Komisarenko M; Grewal R; Goldberg H; Salem S; Jain K; Oliaei A; Horyn I; Timilshina N; Zlotta A; Hamilton R; Kulkarni G; Fleshner N; Alibhaic SMH; Finelli A
    J Urol; 2020 Sep; 204(3):476-482. PubMed ID: 32259466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy.
    Savdie R; Horvath LG; Benito RP; Rasiah KK; Haynes AM; Chatfield M; Stricker PD; Turner JJ; Delprado W; Henshall SM; Sutherland RL; Kench JG
    BJU Int; 2012 Jun; 109(12):1794-800. PubMed ID: 21992536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of biochemical recurrence after Retzius-sparing robot-assisted radical prostatectomy: Analysis of 359 cases with a median follow-up period of 26 months.
    Abdel Raheem A; Chang KD; Alenzi MJ; Ham WS; Han WK; Choi YD; Rha KH
    Int J Urol; 2018 Dec; 25(12):1006-1014. PubMed ID: 30276864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What are the factors associated with short prostate specific antigen doubling time after radical prostatectomy? A report from the SEARCH database group.
    Teeter AE; Bañez LL; Presti JC; Aronson WJ; Terris MK; Kane CJ; Amling CL; Freedland SJ;
    J Urol; 2008 Nov; 180(5):1980-4; discussion 1985. PubMed ID: 18801519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological and 3 Tesla Volumetric Magnetic Resonance Imaging Predictors of Biochemical Recurrence after Robotic Assisted Radical Prostatectomy: Correlation with Whole Mount Histopathology.
    Tan N; Shen L; Khoshnoodi P; Alcalá HE; Yu W; Hsu W; Reiter RE; Lu DY; Raman SS
    J Urol; 2018 May; 199(5):1218-1223. PubMed ID: 29128577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G; Agamy MA; Alenda O; Allory Y; Mouracade P; Vordos D; Hoznek A; Abbou CC; de la Taille A; Salomon L
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More Favorable Pathological Outcomes in Men with Low Risk Prostate Cancer Diagnosed on Repeat versus Initial Transrectal Ultrasound Guided Prostate Biopsy.
    ElShafei A; Nyame Y; Kara O; Badawy A; Amujiogu I; Fareed K; Klein E; Jones JS
    J Urol; 2016 Jun; 195(6):1767-72. PubMed ID: 26724397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics and outcomes of HIV-seropositive men treated with surgery for prostate cancer.
    Izadmehr S; Leapman M; Hobbs AR; Katsigeorgis M; Nabizada-Pace F; Jazayeri SB; Samadi DB
    Int Urol Nephrol; 2016 Oct; 48(10):1639-45. PubMed ID: 27318820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radical prostatectomy and positive surgical margins: relationship with prostate cancer outcome.
    De La Roca RL; Da Cunha IW; Bezerra SM; Da Fonseca FP
    Int Braz J Urol; 2014; 40(3):306-15. PubMed ID: 25010296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, Pathological and Oncologic Findings of Radical Prostatectomy with Extraprostatic Extension Diagnosed on Preoperative Prostate Biopsy.
    Faisal FA; Tosoian JJ; Han M; Macura KJ; Pavlovich CP; Lotan TL
    J Urol; 2019 May; 201(5):937-942. PubMed ID: 30414957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment.
    Loeb S; Folkvaljon Y; Robinson D; Schlomm T; Garmo H; Stattin P
    Eur Urol; 2016 Nov; 70(5):824-828. PubMed ID: 26743040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship and significance of greatest percentage of tumor and perineural invasion on needle biopsy in prostatic adenocarcinoma.
    Rubin MA; Bassily N; Sanda M; Montie J; Strawderman MS; Wojno K
    Am J Surg Pathol; 2000 Feb; 24(2):183-9. PubMed ID: 10680885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate Cancer.
    Muralidhar V; Mahal BA; Butler S; Lamba N; Yang DD; Leeman J; D'Amico AV; Nguyen PL; Trinh QD; Orio PF; King MT
    J Urol; 2019 Nov; 202(5):973-978. PubMed ID: 31144590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostatic ductal adenocarcinoma variant predicts worse pathological and oncological outcomes: Insight from over 1000 consecutive patients from a large prospective uro-oncology registry.
    Tan YG; Khalid F; Huang HH; Chen K; Tay KJ; Lau WKO; Cheng CWS; Ngo NT; Yuen JSP
    Prostate; 2021 Mar; 81(4):242-251. PubMed ID: 33428259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immediate versus delayed prostatectomy: Nationwide population-based study (.).
    Loeb S; Folkvaljon Y; Robinson D; Makarov DV; Bratt O; Garmo H; Stattin P
    Scand J Urol; 2016 Aug; 50(4):246-54. PubMed ID: 27067998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological Outcomes After Radical Prostatectomy for High-Risk Prostate Cancer Based on New Gleason Grouping System: A Validation Study From University of Southern California With 3,755 Cases.
    Djaladat H; Amini E; Xu W; Cai J; Daneshmand S; Lieskovsky G
    Prostate; 2017 May; 77(7):743-748. PubMed ID: 28144967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perineural invasion status, Gleason score and number of positive cores in biopsy pathology are predictors of positive surgical margin following laparoscopic radical prostatectomy.
    Yang R; Cao K; Han T; Zhang YF; Zhang GT; Xu LF; Lian HB; Li XG; Guo HQ
    Asian J Androl; 2017; 19(4):468-472. PubMed ID: 27004537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.